Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00990665 · ClinicalTrials.gov registry record · NA
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
A NA study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 178
- Enrollment target
NCT00990665 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 178 participants.
The verdict
NCT00990665, a NA study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 178 participants
- Enrollment target
Study Summary
The objective of this study is to assess the safety and efficacy of the Quartet™ lead and Promote Q® device system in a patient population indicated for cardiac resynchronization therapy.
Interventions
- DEVICE CRT-D and LV lead (Quartet™ lead and Promote Q® device system)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 178 participants |
| Start Date | 2009-09 |
| Est. Completion | 2012-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00990665
The ClinicalTrials.gov registry entry for NCT00990665 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 178 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CRT-D and LV lead (Quartet™ lead and Promote Q® device system) is the first listed.
NCT00990665 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00990665 about?
NCT00990665 is a clinical study titled "Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study". The objective of this study is to assess the safety and efficacy of the Quartet™ lead and Promote Q® device system in a patient population indicated for cardiac resynchronization therapy.
What is the current status of trial NCT00990665?
This trial is currently completed. It is a NA study. The enrollment target is 178 participants. The study started on 2009-09. Estimated completion is 2012-07.
What interventions are being tested in trial NCT00990665?
The interventions under investigation include: CRT-D and LV lead (Quartet™ lead and Promote Q® device system) (DEVICE).
Who is sponsoring clinical trial NCT00990665?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.